136 related articles for article (PubMed ID: 156038)
1. Plasminogen activation transforms the morphology of quiescent 3T3 cell monolayers and initiates growth.
Whur P; Silcox JJ; Boston JA; Williams DC
Br J Cancer; 1979 Jun; 39(6):718-30. PubMed ID: 156038
[TBL] [Abstract][Full Text] [Related]
2. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
Takada A; Takada Y
Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
[TBL] [Abstract][Full Text] [Related]
3. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
4. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the urokinase and streptokinase activation properties of the native and lower molecular weight forms of sheep plasminogen.
Paoni NF; Castellino FJ
J Biol Chem; 1979 Mar; 254(6):2064-70. PubMed ID: 154519
[No Abstract] [Full Text] [Related]
6. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
Thorsen S
Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
[No Abstract] [Full Text] [Related]
7. Urokinase regulates embryonic cardiac cushion cell migration without converting plasminogen.
Gorny KN; Brauer PR
Anat Rec; 1999 Nov; 256(3):269-78. PubMed ID: 10521785
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator (urokinase) causes vascularization of the cornea.
Berman M; Winthrop S; Ausprunk D; Rose J; Langer R; Gage J
Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):191-9. PubMed ID: 6173346
[TBL] [Abstract][Full Text] [Related]
9. Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.
Takada A; Takada Y
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):411-9. PubMed ID: 6459659
[No Abstract] [Full Text] [Related]
10. Activation of human Glu-plasminogen to Glu-plasmin by urokinase in presence of plasmin inhibitors. Streptomyces leupeptin and human plasma alpha1-antitrypsin and antithrombin III (plus heparin).
Summaria L; Boreisha IG; Arzadon L; Robbins KC
J Biol Chem; 1977 Jun; 252(11):3945-51. PubMed ID: 140876
[No Abstract] [Full Text] [Related]
11. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
Berkenpas MB; Quigley JP
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7768-72. PubMed ID: 1652763
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
13. Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).
Fears R; Dodd I; Ferres H; Robinson JH
Biochem J; 1990 Mar; 266(3):693-6. PubMed ID: 2139324
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
15. Effects of Pseudomonas fluorescens M3/6 bacterial protease on plasmin system and plasminogen activation.
Frohbieter KA; Ismail B; Nielsen SS; Hayes KD
J Dairy Sci; 2005 Oct; 88(10):3392-401. PubMed ID: 16162512
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of plasmin catalyzed conversion of single-chain to two-chain urokinase-type plasminogen activator by sulfated polysaccharides.
Rydzewski A; Takada Y; Takada A
Thromb Haemost; 1989 Sep; 62(2):752-5. PubMed ID: 2479114
[TBL] [Abstract][Full Text] [Related]
17. Activation of Glu-plasminogen by urokinase in the presence of fibrinogen, fibrin, and SK-potentiator.
Takada A; Takada Y
Thromb Res; 1981 May; 22(4):497-501. PubMed ID: 6457416
[No Abstract] [Full Text] [Related]
18. Plasminogen activation in the bovine udder.
Hedkvist L; Höglund S; Persson K; Holmberg O
Acta Vet Scand; 1989; 30(1):103-5. PubMed ID: 2528899
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator is an apparent lymphocyte mitogen.
Cohen SD; Israel E; Spiess-Meier B; Wainberg MA
J Immunol; 1981 Apr; 126(4):1415-20. PubMed ID: 6259259
[TBL] [Abstract][Full Text] [Related]
20. [Enzymatic fibrinolytic agents].
Jamet M; Granthil C; Levy G
Ann Anesthesiol Fr; 1978; 19(8):693-6. PubMed ID: 31112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
